OraSure Technologies Inc - רווח נקי למניה בארבעת הרבעונים האחרונים OSUR

This chart illustrates the market value of OraSure Technologies (OSUR), which reports earnings per share of 14.80, reflecting the performance of its disease diagnostics business. OraSure Technologies relies on the synergy between scientists and engineers to develop rapid tests. Management successfully diversified revenue streams post-pandemic by implementing molecular systems. Patent protection, FDA certification, and close ties with the public healthcare sector ensure the stability of its market position.
OraSure Corp - פילוחים אנליטיים ומדדי מפתח (OSUR)

Year-over-year (YoY) EPS growth (TTM) measures the change in net income per share over a rolling year, neutralizing seasonal reporting fluctuations. Investors utilize this metric to evaluate profit generation efficiency and identify trend reversal points. Analyzing the percentage dynamics of EPS YoY TTM reveals revenue stagnation for OraSure Technologies (OSUR). This is a result of declining pricing power and competition from low-cost rapid test alternatives.